Organized by Eurofins Transplant Genomics
At this event, we will be hosting John Friedewald, MD, FAST, FASN from Northwestern University’s Comprehensive Transplant Center as he discusses non-invasive genetic biomarkers. These biomarkers offer transplant teams a clinically-valid alternative to surveillance biopsies for detecting incipient rejection. This presentation will explore the use of a novel panel of complementary biomarkers (the OmniGraf™ rejection biomarker panel, from Eurofins Transplant Diagnostics) through a discussion of several case studies where biomarker guidance informed intervention and improved outcomes.
